BOT 6.15% 34.5¢ botanix pharmaceuticals ltd

Ann: Update on BTX 1801 Phase 2a Clinical Study, page-19

  1. 3,025 Posts.
    lightbulb Created with Sketch. 402
    I am not fussed over the results coming in Jan. I like they have successfully completed the BTX 1801 antimicrobial Phase 2a clinical study and -Results from the BTX 1801 Phase 2a clinical study will support an IND filing and rapid progression into pivotal studies for FDA registration.

    Some nice wording there!! Dont expect anything in the first 2weeks of Jan due to Holidays IMO. From then on though, hopefully we are off. If people can see this has been successfully completed and can wait 4 or so weeks they will be rewarded.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
0.020(6.15%)
Mkt cap ! $624.4M
Open High Low Value Volume
32.5¢ 34.5¢ 32.5¢ $2.676M 7.955M

Buyers (Bids)

No. Vol. Price($)
2 19000 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 48210 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.